Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16Ink4a, p19Arf, p53, and p21Waf1/Cip1

Molecular Carcinogenesis

Volumn 32, Issue 1, 2001, Pages 9-18

  Nojima, Dana ^a   Nakajima, Koichi ^a   Li, Long Cheng ^a   Franks, Joseph ^a   Ribeiro Filho, Leopoldo ^a   Ishii, Nobuhisa ^a   Dahiya, Rajvir ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cultured tumor cells; Experimental liver tumors; Mice

Indexed keywords

PROTEIN P16; PROTEIN P19; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL MATURATION; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; GENE DELETION; LIVER CELL CULTURE; LIVER TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRAVIOLET IRRADIATION;

ALKYLATING AGENTS; ANIMALS; BLOTTING, WESTERN; CELL AGING; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DIETHYLNITROSAMINE; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034796824     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.1059     Document Type: Article

References (78)

1. Current theories of biological aging
2. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines
3. The relationship between in vitro transformation and tumor formation in vivo
4. Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens
5. Senescence as a mode of tumor suppression
6. Cancer cell cycles
7. The Pezcoller lecture: Cancer cell cycles revisited
8. The INK4A/ARF locus and its two gene products
9. G1 phase progression: Cycling on cue
10. Principles of CDK regulation
11. INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status
12. INK4a tumor suppressor versus other INK4 family members during mouse development and aging
13. The p53 pathway
14. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
15. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
16. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF
17. ARF, participates in a regulatory feedback loop with p53 and MDM2
18. ARF
19. WAF1, a potential mediator of p53 tumor suppression
20. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of cyclin dependent kinases
21. p21 is a universal inhibitor of cyclin kinases
22. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
23. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
24. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras
25. Kip1 without activating cyclin D-dependent kinases
26. INK4a
27. ARF links the tumour suppressor p53 to Ras
28. Senescence of human fibroblasts induced by oncogenic Raf
29. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
30. ARF tumor suppressor
31. ARF links the tumor suppressors RB and p53
32. ARF tumor suppressor
33. Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation
34. Replicative senescence: Implications for in vivo aging and tumor suppression
35. Aging and cancer: The double-edged sword of replicative senescence
36. Cellular senescence and cancer
37. Can ends justify the means? Telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells
38. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
39. Cellular senescence in telomerase-expressing Syrian hamster embryo cells
40. A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization
41. Frequent deletion in chromosome 4 and duplication of chromosome 15 in liver epithelial cells derived from long-term culture of C3H mouse hepatocytes
42. High colony forming capacity of primary cultured hepatocytes as a dominant trait in hepatocarcinogenesis-susceptible and -resistant mouse strains
43. Most liver epithelial cell lines from C3B6F1 mice exhibit parentally-biased loss of heterozygosity at the Lci (liver cell immortalization) locus on chromosome 4
44. Gain of chromosomes 15 and 19 is frequent in both mouse hepatocellular carcinoma cell lines and primary tumors, but loss of chromosomes 4 and 12 is detected only in the cell lines
45. Fine mapping of smallest common regions of deletion on chromosome 12 in liver epithelial and hepatocellular carcinoma cell lines from B6C3F1 and C3B6F1 mice
46. Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in gamma-radiation-induced mouse primary thymic lymphomas
47. Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36
48. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: Frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes
49. Chromosomal and genetic alterations of 7,12-dimethylbenz[a]anthracene-induced melanoma from TP-ras transgenic mice
50. 15INK4b genes
51. Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors
52. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
53. β-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice
54. Mutation of β-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis
55. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation
56. Analysis of loss of heterozygosity in murine hepatocellular tumors
57. Indistinct cell cycle checkpoint after u.v. damage in H-ras-transformed mouse liver cells despite normal p53 gene expression
58. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse
59. Use of a low-speed, iso-density Percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations
60. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
61. A cell cycle regulator potentially involved in genesis of many tumor types
62. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
63. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
64. ARF
65. p16 Gene overexpression in mouse bladder carcinomas
66. INK4a in mouse lung tumors
67. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
68. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1
69. The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
70. ARF act in overlapping pathways in cellular immortalization
71. WAF1/CIP1 expression in normal and neoplastic tissues
72. p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma
73. Cip1 in muscle and other terminally differentiating cells
74. Cip1/Waf1/Sdi1 are icentified by HPV16-E6 interaction and correlate with life span and cellular senescence
75. Functional role of p21 during the cellular response to stress
76. CDK inhibitors: Positive and negative regulators of G1-phase progression
77. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts
78. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts